J&J Settles West Virginia Opioid Litigation for $99 Million

J&J Settles West Virginia Opioid Litigation for $99 Million
The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange on May 29, 2019. Brendan McDermid/Reuters
|Updated:

Johnson & Johnson said on Monday it agreed to pay $99 million to settle claims by West Virginia that it helped fuel an opioid addiction crisis in the state, removing the company from an ongoing trial that began earlier this month.

West Virginia is still pursuing claims against Teva Pharmaceuticals Industries Ltd. and AbbVie Inc.’s Allergan in the Kanawha County Circuit Court trial for their alleged role in the crisis.